Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 509.00
Bid: 506.00
Ask: 512.00
Change: 11.00 (2.20%)
Spread: 6.00 (1.186%)
Open: 503.00
High: 512.00
Low: 508.00
Prev. Close: 501.00
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

9 Feb 2015 07:00

RNS Number : 3441E
Oakley Capital Investments Limited
09 February 2015
 

09 February 2015

 

Oakley Capital Investments Limited ("OCIL" or the "Company")

 

Trading Update for the 12 months ended 31 December 2014

 

· NAV per share (unaudited) expected to be in the range of £1.99 - £2.01

· Four acquisitions in the period with a total enterprise value of £227 million

· Successful exits, including a post reporting period disposal, achieved a gross money multiple of 2.6x and an IRR of 58%, returning £73 million to the Company

· Final close of Fund II with total commitments of €524 million

 

Oakley Capital Investments Limited (AIM: OCL), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. ("Fund I") and its successor fund, Oakley Capital Private Equity II ("Fund II") (together the "Funds"), today announces a trading update for the 12 months ended 31 December 2014.

 

The Company, through its investment in Fund I, has an indirect interest in each of Fund I's portfolio companies representing 65.5% of Fund I's total commitments; and through its investment in Fund II, an indirect interest in each of Fund II's portfolio companies representing 38.1% of Fund II's total commitments.

 

Oakley Capital Limited, OCIL's investment adviser, estimates that the Company's net asset value, which is subject to the completion of the 31 December 2014 audit of the Funds, and the Company, will be in the range of £255 million to £257 million, equating to a net asset value per share of between £1.99 to £2.01 (31 December 2013: £2.00). The OCIL net asset value is made up of cash, the investments in the Funds, short-term bridging finance for the Funds and loans provided to a number of the portfolio companies.

 

The Board has authorised a share buy-back programme of up to 7 million ordinary shares in the Company at prices below the estimated net asset value per share.

 

 

Key Highlights 

· Fund II closed in December 2014 with total commitments of €524 million, including €200 million from the Company and over 10% of commitments from management teams Oakley Capital Private Equity has previously backed. 

· Fund II's rapid capital deployment, including acquisitions of:

- Majority stakes in North Technology Group LLC ("North Sails") and North Sails Europe LLC ("NSE") and North Sail's subsequent acquisition of Tomasoni Topsail SpA. Collectively these acquisitions will enable the leading marine technology group, North Sails, to operate on a global basis, under common ownership, and expand its branded apparel business.  

- A 51% stake in Educas Europe Investments LLP ("a sister partnership to Educas Investments LLP, one of Fund I's portfolio investments), established to acquire independent schools in Europe, which has subsequently acquired Bearwood College and Fulham Prep School. 

- A majority stake in Facile.it, Italy's leading price comparison site for motor insurance, energy, telecoms and personal finance. 

- In the post reporting period, Damovo II Sarl, a provider of enterprise information communication technology (ICT) services and solutions, which will seek to replicate the success of Daisy Group plc ("Daisy") through a European roll-up strategy led by founder of Daisy, Matthew Riley.  

· Strong disposals, including,

- Fund I's disposal of its 13.6% shareholding in Daisy, providing a gross money multiple of 36x and an IRR of 71%.

 

- In the post reporting period, Fund II, together with its co-owner Bellaxa AG, sold intergenia Holding GmbH and its subsidiaries ("intergenia") to HEG Co. GmbH ("Host Europe"), representing a gross money multiple of 1.5x and IRR of 47% for Fund II in under 12 months.

 

 

Peter Dubens, Director, commented:

 

"I am delighted that the second fund exceeded its target and closed with total commitments of €524 million. To-date 42% of commitments to Fund II have been drawn and have funded an attractive portfolio of investments.

 

NAV performance in the period was somewhat attenuated by the weakening of the Euro during the year. Nevertheless significant disposals from both Funds, specifically the exits from Daisy and intergenia both of which delivered good returns, demonstrates Oakley's ability to deliver strong investment returns for our investors. Since inception in 2007, the Funds have returned an aggregate gross money multiple of 2.6x and an IRR of 45%, from realised investments."

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens

 

FTI Consulting

+44 20 3727 1000

Edward Bridges / Emily Desmier

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

 

 

About Oakley Capital Investments Limited ("OCIL")

Oakley Capital Investments Limited is a Bermudan based company listed on AIM. OCIL seeks to

provide investors with long term capital appreciation through its investments in Oakley Capital Private Equity L.P. and Oakley Capital Private Equity II and, over time, through co-investment opportunities.

 

About Oakley Capital Private Equity L.P. and Oakley Capital Private Equity II

Oakley Capital Private Equity L.P. and its successor fund, Oakley Capital Private Equity II, are both unlisted UK and European mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of both funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. Both funds seek to invest in companies with scale in their industry subsectors, thereby creating a sustainable earnings stream which should command a premium on exit.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSLFWMFISEDE
Date   Source Headline
28th Jun 20247:00 amRNSOakley agrees sale of its investment in idealista
11th Jun 20247:00 amRNSOakley to invest in cybersecurity firm I-TRACING
7th Jun 20247:00 amRNSDirector Dealing
3rd Jun 20243:43 pmRNSResult of AGM
28th May 20247:00 amRNSOakley Capital invests in ProductLife Group
14th May 20247:00 amRNSOakley Capital invests in vitroconnect
8th May 20247:00 amRNSNotice of Annual General Meeting
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.